Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jun 10 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release regarding the receipt of an Establishment Inspection Report for its API manufacturing facility at Dabhasa. The facility was inspected by the USFDA and classified as Voluntary Action Indicated, with the inspection confirmed as closed. This announcement serves as a disclosure in accordance with regulatory requirements.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases